Verrica Pharmaceuticals Inc. (VRCA) Operating cash flow 2017–2025
Verrica Pharmaceuticals Inc. (VRCA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$17.6MFY2025 · since FY2017: -$4.6M → -$17.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$17.6M | +71.1% |
| FY2024 | -$60.9M | -57.9% |
| FY2023 | -$38.6M | -106.8% |
| FY2022 | -$18.6M | +32.4% |
| FY2021 | -$27.6M | +8.7% |
| FY2020 | -$30.2M | -10.2% |
| FY2019 | -$27.4M | -53.3% |
| FY2018 | -$17.9M | -290.0% |
| FY2017 | -$4.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More VRCA financial trends
VRCA RevenueVRCA Net incomeVRCA Net marginVRCA Gross profitVRCA Gross marginVRCA Operating incomeVRCA Operating marginVRCA Free cash flowVRCA Capital expendituresVRCA Return on equityVRCA Stock buybacksVRCA Dividends paidVRCA Total assetsVRCA Total liabilitiesVRCA Shareholders’ equityVRCA overview →